ANRO

SEC filing ANRO Appoints Dr. Andrew Miller to Board, Grants $400K Option, $45K Cash Retainer

5d ago

News Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal

14d ago

News Alto Neuroscience GAAP EPS of -$0.80

20d ago

SEC filing ANRO Announces $120M Private Placement Led by Commodore Capital, Funds ALTO-207 Phase 3 in TRD

78d ago

News Alto Neuroscience GAAP EPS of -$2.19 beats by $0.06

78d ago

SEC filing ANRO Acquires ALTO-207 for TRD, $50M PIPE, $177M Cash to 2028, Phase 2b 2026, Lancet d=0.87

78d ago

Scanner Unusual volume (z=2.6)

163d ago

Scanner Unusual volume (z=2.6)

164d ago

News ADDF Bolsters Leadership Amid Transformative Moment in Alzheimer's Research, Naming Gavin Cook and David Dolby to its Board and Appointing Jane McIntosh as Interim CEO

168d ago

Scanner Unusual volume (z=7.0)

168d ago